
IMPROVING OUR PATIENTS’
QUALITY OF LIFE
Adacyte Therapeutics is a pioneering company committed to the development and commercialization of unique and innovative therapeutic solutions for the treatment of complex diseases.
Learn moreOur commitment is taking care of your health
Our genuine interest in patients voice inspires our vision to continue globally developing GMA (Granulocyte-Monocyte Apheresis) as an effective and safe treatment option for IBD and other autoimmune diseases. GMA is today a growing and emerging medical technology which offers a therapeutic alternative to the standard treatments.

Our WorkTherapeutic Areas
Autoimmune diseases directly affect more than 27 million people in Europe alone
HEALTHCARE PROFESSIONAL AREA
Adacyte Therapeutics is a multinational company committed to the development of unique health technologies aimed at improving patients’ health and its quality of life.

EDUCATIONAL
CORNER
ADACYTE STORIESLatest News



December 13, 2024
Patologies
Surgery in IBD: when it is necessary, preparation and possible complications. Read moreContact UsFor more information
Contact Us